BoxGroup

BoxGroup is an investment fund company based in New York City.[1] The company was founded in 2007 by David Tisch, grandson of entrepreneurs Laurence A. Tisch, and Adam Rothenberg.[2]

BoxGroup
TypePrivately held company
IndustryVenture capital and private equity
Founded2007 in New York City, United States
Headquarters
New York City
,
United States
Area served
United States and Europe
Key people
  • David Tisch (Co-founder and managing director)
  • Adam Rothenberg (Co-founder and partner)
ServicesSeed funding
Websiteboxgroup.com

BoxGroup invests in the pre-seed and seed rounds of financing for early-stage companies. One of the financing companies they have invested in, is Ramp, a corporate card start-up. [3] The venture capital fund invests in start-up technology businesses in many sectors including marketplaces, e-commerce, SAAS, and financial tech.[1][4][5]

BoxGroup was among the top three most active United States-based micro venture capital firms in 2014.[6] The company was listed in Poet & Quants "Top 20 Investors Behind MBA Startups" and has more than 230 investments startup companies including Vine, Groupme, Warby Parker and Behance.[7][2][8][9]

References
  1. Nicolette Tuono (February 18, 2014). "A New York VC Spotlight: Adam Rothenberg". Alley Watch. Retrieved March 7, 2016.
  2. Nathan Allen (March 2, 2015). "The top 20 investors behind MBA startups". Poets & Quants. Retrieved March 7, 2016.
  3. "Ramp, a Brex and Amex rival, raises $25 million for a new corporate card". Fortune. Retrieved 2020-02-21.
  4. "Jessica Kreps, Adam Rothenberg". The New York Times. October 27, 2013. Retrieved March 7, 2016.
  5. "Investability of a startup: Interview with BoxGroup's David Tisch". Under 30 CEO. 2016. Retrieved March 7, 2016.
  6. Tanya Benedicto Klich (February 19, 2015). "VC 100: The top investors in early-stage startups". Entrepreneur. Retrieved March 7, 2016.
  7. "How the quiet Adam Rothenberg become number two at hot startup incubator, TechStars NY". Venture Beat. March 12, 2012. Retrieved March 7, 2016.
  8. Keenan, Joseph (30 November 2022). "Vial reels in $67M in series B fund raising; adds NEXT Oncology to network". Fierce Biotech.
  9. Gormley, Brian (30 November 2022). "General Catalyst Backs Clinical Trials Startup Vial". Wall Street Journal.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.